Clinical Trial Detail

NCT ID NCT04134559
Title Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Allison O'Neill
Indications

hepatocellular carcinoma

Therapies

Pembrolizumab

Age Groups: adult child

No variant requirements are available.